Global Targeted Protein Degradation Market –By Type of Degrader
Global Targeted Protein Degradation Market – Target Indication
Global Targeted Protein Degradation Market – By Region
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Targeted Protein Degradation Market Snapshot
Chapter 4. Global Targeted Protein Degradation Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type of Degrader Estimates & Trend Analysis
5.1. by Type of Degrader & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type of Degrader:
5.2.1. SERD
5.2.2. PROTAC
5.2.3. Molecular Glue
Chapter 6. Market Segmentation 2: by Target Indication Estimates & Trend Analysis
6.1. by Target Indication & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Target Indication:
6.2.1. Breast Cancer
6.2.2. Myeloma
Chapter 7. Targeted Protein Degradation Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by Type of Degrader, 2021-2034
7.1.2. North America Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by Target Indication, 2021-2034
7.1.3. North America Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.2. Europe
7.2.1. Europe Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by Type of Degrader, 2021-2034
7.2.2. Europe Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by Target Indication, 2021-2034
7.2.3. Europe Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.3. Asia Pacific
7.3.1. Asia Pacific Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by Type of Degrader, 2021-2034
7.3.2. Asia Pacific Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by Target Indication, 2021-2034
7.3.3. Asia Pacific Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.4. Latin America
7.4.1. Latin America Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by Type of Degrader, 2021-2034
7.4.2. Latin America Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by Target Indication, 2021-2034
7.4.3. Latin America Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.5. Middle East & Africa
7.5.1. Middle East & Africa Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by Type of Degrader, 2021-2034
7.5.2. Middle East & Africa Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by Target Indication, 2021-2034
7.5.3. Middle East & Africa Targeted Protein Degradation Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Arvinas
8.2.2. Bristol-Myers Squibb
8.2.3. C4 Therapeutics
8.2.4. Loxo Oncology
8.2.5. Olema Oncology
8.2.6. Radius Health
8.2.7. AstraZeneca
8.2.8. Roche
8.2.9. BeiGene
8.2.10. InnoCare Pharma
8.2.11. Kangpu Biopharmaceuticals
8.2.12. Kintor Pharmaceuticals
8.2.13. Medivir
8.2.14. Monte Rosa Therapeutics
8.2.15. Ranok Therapeutics
8.2.16. Sanofi
8.2.17. Zentalis Pharmaceuticals
8.2.18. Eisai Therapeutics
8.2.19. Other Prominent Players
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.